ISO TS 16766-2024 PDF

ISO TS 16766-2024 PDF

Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency

$71.50 $143.00 -50%
Product Code: ISO TS 16766
Stock In Stock
Edition: 1.
Published: 11/2024
Number of Pages: 20
File Size: 1 file, 1 Byte

Available Options

Product Description

Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency

Introduction: During a pandemic, accurate identification and isolation of infected individuals is an effective initial response to secure public health and safety before vaccines are available. The coronavirus disease of 2019 (COVID-19) posed an unprecedented public health emergency, causing many countries to impose restrictions on travel and daily activities to slow the spread of infection. An example where the spread of COVID-19 infection was demonstrated to have been slowed before vaccines became available has been published.[1] Here, a series of interventions, such as the urgent introduction of appropriate emergency use in vitro diagnostic (emergency use-IVD) medical devices, aggressive testing, rigorous contact tracing, etc., were applied in the early stage of the pandemic. Such a series of interventions effectively slowed the spread of infections and succeeded in maintaining public health and safety without the collapse of intensive care capabilities. Often, regulatory authorization of in vitro diagnostic (IVD) medical devices takes months to a year or more to review and approve under a traditional regulatory pathway. Following a global infectious disease outbreak such as severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS), the need for an accelerated regulatory pathway to facilitate the introduction of emergency use-IVD medical devices was recognised. While such pathways (i.e. emergency use authorization processes) have been implemented, the processes

Scope: This document provides guidance to manufacturers on the minimum requirements for the lifecycle management of in vitro diagnostic (IVD) medical devices that are developed in preparation for and in response to a public health emergency involving infectious agents requiring immediate availability of authorized IVD devices. NOTE This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes: following a risk management process; monitoring the device’s post-market performance and quality assurance; implementing a communication system.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO TS 16766-2024 PDF

ISO TS 16766-2024 PDF

$71.50 $143.00